1 terminated. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Terminated 1 |
| Phase 2 | 1 | Terminated 1 |
Follow serum P-component: new trials by email Literature Review of serum P-component trials Research Report on serum P-component
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| L-citrulline Injection in Patients Aged 6-21 Years Old with Sickle Cell Disease Presenting with Vaso-Occlusive Crisis (VOC) L-citrulline, D5 1/2NS - Acute Vaso Occlusive Crisis (VOC) | Phase 1 / Phase 2 | Terminated | Asklepion Pharmaceuticals, LLC | 30 | 2021-04-29 | 2024-09-19 |
Asklepion Pharmaceuticals, LLC (1)
United States (1)